Taught course

Cancer Biology and Therapy

University of Central Lancashire · School of Pharmacy and Biomedical Sciences

Visit the institution website for COVID‑19 updates

Entry requirements

A minimum of a lower second class honours degree of a UK university or its equivalent in a biological discipline, eg biochemistry, physiology, biomedical science. A qualification or experience deemed to be equivalent to the above. IELTS at 6.5.

Months of entry


Course content

1 in 3 people are affected by cancer; it remains a leading cause of death, but great strides are being made in both our knowledge of basic cancer biology and potential therapies. It is a field of intense interest and significance with new discoveries making significant contributions to how we are able to diagnose and treat this ancient adversary. This course provides specialist theoretical and practical knowledge of both basic molecular, genetic and biological processes associated with cancer together with an emphasis on the advances in pathology, diagnosis and therapy. The award will prepare the student for further study to PhD level or a career in the pharmaceutical, biotechnology or healthcare industries.

The School of Pharmacy and Biomedical Sciences possesses a state-of-the-art research facility dedicated to biomedical postgraduate research, in which current research programmes relevant to the field of cancer are established. UCLan is a founder member of Brain TumourNorth West, (BTNW), the largest co-ordinated research group working on brain tumour in the UK. In addition, staff have close links with clinical specialists in cancer who will be contributing to the course.

For the taught MSc, the course is offered on a one-year full-time basis, taught over three terms. It includes 6 taught modules in the first two terms in which all lecture material will be provided on our VLE to enable access. A research project occupies the whole of the third term in order to allow you to conduct a detailed investigation into a particular aspect of cancer biology or therapy of your choice. For the MRes pathway, you will have to apply for the taught MSc and complete the modules for semester one, before transfering over to the MRes. With this course you will spend both semesters two and three conducting an in-depth investigration into a particular aspect of cancer biology or therapy, allowing you more time to conduct your research.

The course also includes guest lecturers from Royal Preston Hospital, including: Consultant Neurosurgeons; Consultant Immunologists; Consultant Oncologists and Consultant Neuropathologists - who will give lectures on their personal experiences and their work within the NHS.

Fees and funding

UK students

Qualification, course duration and attendance options

  • MSc
    full time
    12 months
    • Campus-based learningis available for this qualification
  • MSc(Res)
    full time
    12 months
    • Campus-based learningis available for this qualification

Course contact details

Course Enquiries
+44 (0) 1772 892 400